CHTP Stock Recent News Chelsea Therapeutics International (CHTP)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chelsea Therapeutics International (CHTP) 6.52 $CHTP

Shares of CHTP Up 29.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Nov 03, 9:23AM CST
SmarTrend identified an Uptrend for Chelsea Therapeutics International (NASDAQ:CHTP) on January 15th, 2014 at $5.03. In approximately 10 months, Chelsea Therapeutics International has returned 29.62% as of today's recent price of $6.52.
CHTP: 6.52 (-0.03)

Uptrend Call Working As Chelsea Therapeutics International Stock Rises 29.6% (CHTP)
Comtex SmarTrend(R) - Fri Oct 24, 5:15PM CDT
SmarTrend identified an Uptrend for Chelsea Therapeutics International (NASDAQ:CHTP) on January 15th, 2014 at $5.03. In approximately 9 months, Chelsea Therapeutics International has returned 29.62% as of today's recent price of $6.52.
CHTP: 6.52 (-0.03)

Chelsea Therapeutics International Has Returned 29.6% Since SmarTrend Recommendation (CHTP)
Comtex SmarTrend(R) - Fri Oct 10, 9:46AM CDT
SmarTrend identified an Uptrend for Chelsea Therapeutics International (NASDAQ:CHTP) on January 15th, 2014 at $5.03. In approximately 9 months, Chelsea Therapeutics International has returned 29.62% as of today's recent price of $6.52.
CHTP: 6.52 (-0.03)

Chelsea Therapeutics International Shares Up 29.6% Since SmarTrend's Buy Recommendation (CHTP)
Comtex SmarTrend(R) - Thu Sep 18, 9:56AM CDT
SmarTrend identified an Uptrend for Chelsea Therapeutics International (NASDAQ:CHTP) on January 15th, 2014 at $5.03. In approximately 8 months, Chelsea Therapeutics International has returned 29.62% as of today's recent price of $6.52.
CHTP: 6.52 (-0.03)

29.6% Return Seen to Date on SmarTrend Chelsea Therapeutics International Call (CHTP)
Comtex SmarTrend(R) - Thu Sep 11, 9:36AM CDT
SmarTrend identified an Uptrend for Chelsea Therapeutics International (NASDAQ:CHTP) on January 15th, 2014 at $5.03. In approximately 8 months, Chelsea Therapeutics International has returned 29.62% as of today's recent price of $6.52.
CHTP: 6.52 (-0.03)

Lundbeck Completes Acquisition of Chelsea Therapeutics
Business Wire - Tue Jun 24, 9:00AM CDT
H. Lundbeck A/S (Lundbeck) today announced that it has completed its acquisition of Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP) (Chelsea) for USD 6.44 per share in cash and non-transferable contingent value rights that may pay up to an additional USD 1.50 per share upon achievement of certain sales milestones, in each case without interest and subject to any required withholding of taxes. As a result of the acquisition, Chelsea became a wholly-owned indirect subsidiary of Lundbeck, and shares of Chelsea common stock will no longer be listed on the NASDAQ Capital Market.
CHTP: 6.52 (-0.03)

Downgrade Alert for Chelsea Therapeutics International (CHTP)
Comtex SmarTrend(R) - Tue Jun 24, 6:55AM CDT
Chelsea Therapeutics International (NASDAQ:CHTP) was downgraded from Outperform to Neutral at Wedbush today. The stock closed yesterday at $6.52 on volume of 6.1 million shares, above average daily volume of 6.1 million. Chelsea Therapeutics International Ltd. is a biopharmaceutical company developing a pipeline of low toxicity antifolate compounds engineered to have anti-inflammatory and anti-tumor activity. The Company's lead candidate is in development as a metabolically inert treatment alternative to Methotrexate for rheumatoid arthritis, psoriasis, and other disorders.
CHTP: 6.52 (-0.03)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 2

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 1

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 1

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 1

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 0

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 2

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 2

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 2

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading

Top 5 Most Recently Viewed Articles

Legal Opportunities for Capricor Investors Facing Losses

Updated Category News Views 154

Capricor Therapeutics Faces Legal Scrutiny Capricor Therapeutics, Inc. (NASDAQ: CAPR) finds itself at the center of a significant legal issue as investors come forth with claims of securities fraud. The Rosen Law Firm, a leader in investor rights, has highlighted an important opportunity for those who purchased Capricor's securities during a specified period. This legal...

Continue Reading
Revolutionizing Therapeutics: Harbour BioMed’s AI Innovations

Updated Category News Views 221

Revolutionizing Therapeutics with AI Technology Harbour BioMed, a renowned biopharmaceutical leader, has made significant advancements in the field of drug discovery. The company specializes in developing novel antibody therapeutics primarily targeted at immunology and oncology. Their latest innovation arrives with the launch of the first fully human Generative AI HCAb...

Continue Reading
Intuit Surges in Premarket Trading Amid Strong Earnings Report

Updated Category News Views 152

Intuit Inc Sees Promising Growth in Premarket Trading Intuit Inc (NASDAQ: INTU) has experienced a significant rise in its shares during premarket trading sessions, primarily due to its impressive financial performance in the recent quarter. The company's earnings report has exceeded market expectations, showcasing its ability to thrive in a competitive landscape....

Continue Reading
HR Acuity and Labor Relations Institute Forge Dynamic Alliance

Updated Category News Views 235

HR Acuity Announces Innovative Partnership with Labor Relations Institute HR Acuity has joined forces with Labor Relations Institute Consulting Services (LRICS) to foster a new era of collaboration among labor relations professionals. This exciting initiative aims to extend support to the increasingly critical domain of labor relations, particularly as workplace dynamics...

Continue Reading
Subsea7 Excels with New Offshore Development Contract

Updated Category News Views 186

Subsea7 Engages in New Offshore Project In a significant development for Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY), the company has secured a pivotal contract with ConocoPhillips Skandinavia AS for conducting a front-end engineering and design (FEED) study. This contract pertains to the Previously Produced Fields (PPF) project offshore, which marks an exciting stride...

Continue Reading